Literature DB >> 19621722

Pancreatic cancer with distant metastases: a contraindication for radical surgery?

Suguru Yamada1, Tsutomu Fujii, Hiroyuki Sugimoto, Naohito Kanazumi, Hideki Kasuya, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera, Akimasa Nakao.   

Abstract

BACKGROUND/AIMS: The purpose of this study was to analyze cases of resected pancreatic cancer with distant metastasis (M1) and to review the surgical indication for these patients.
METHODOLOGY: Between July 1981 and December 2007, 542 patients with pancreatic cancer underwent surgery at the Department of Surgery II, Nagoya University. These patients included 48 cases of paraaortic lymph node metastases, 11 cases of hepatic metastases and 6 cases of peritoneal metastases. The overall survival rates were evaluated using the Kaplan-Meier method.
RESULTS: Overall survival in patients stratified by M0 and M1 showed significant differences between M0 and M1 cases. As for hepatic metastases and peritoneal metastases, no significant difference in survival was observed between resected and unresected cases. However, survival in cases of paraaortic lymph node metastases was better than that in unresected cases, although this observation was not statistically significant.
CONCLUSIONS: Hepatic or peritoneal metastases are contraindications for radical surgery for pancreatic cancer. On the other hand, patients with paraaortic lymph node metastases are relatively promising targets for radical surgery, and radical resection with extended lymphadenectomy remain an option for these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19621722

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2010-02-27

Review 2.  Advances in chemotherapy for pancreatic cancer.

Authors:  Bhawna Sirohi; Ashish Singh; Shaheenah Dawood; Shailesh V Shrikhande
Journal:  Indian J Surg Oncol       Date:  2015-01-13

Review 3.  Pancreatic cancer and liver metastases: state of the art.

Authors:  Eugen Bellon; Florian Gebauer; Michael Tachezy; Jakob R Izbicki; Maximilian Bockhorn
Journal:  Updates Surg       Date:  2016-11-10

4.  Incidence and prognostic impact of para-aortic lymph nodes metastases during pancreaticoduodenectomy for peri-ampullary cancer.

Authors:  Gennaro Nappo; Domenico Borzomati; Giuseppe Perrone; Sergio Valeri; Michela Amato; Tommasangelo Petitti; Roberto Coppola
Journal:  HPB (Oxford)       Date:  2015-09-03       Impact factor: 3.647

5.  Safety and efficacy of locoregional therapy for metastatic pancreatic ductal adenocarcinoma to the liver: a single-center experience.

Authors:  Ryan Earl Bailey; Phani Keerthi Surapaneni; Jacob Core; Lucas Lauar Cortizo Vidal; Jordan LeGout; Charles Ritchie; Gregory Frey; J Mark McKinney; David Sella; Ricardo Paz-Fumagalli; Beau Toskich; Kabir Mody
Journal:  J Gastrointest Oncol       Date:  2019-08

6.  Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.

Authors:  Cosimo Sperti; Mario Gruppo; Stella Blandamura; Michele Valmasoni; Gioia Pozza; Nicola Passuello; Valentina Beltrame; Lucia Moletta
Journal:  World J Gastroenterol       Date:  2017-06-28       Impact factor: 5.742

7.  Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC).

Authors:  Florian Gebauer; Alexander Ioannis Damanakis; Dirk Waldschmidt; Christiane Bruns; Felix Popp; Alexander Quaas; Fabian Kütting; Katrin Lutz; Swantje Held; Burkhard Deuß; Tobias Göser
Journal:  BMC Cancer       Date:  2021-11-18       Impact factor: 4.430

8.  Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases?

Authors:  Rachael Chang Lee; Harsh Kanhere; Markus Trochsler; Vy Broadbridge; Guy Maddern; Timothy J Price
Journal:  World J Gastrointest Oncol       Date:  2018-08-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.